SCHEMBL7832840

SCHEMBL7832840

Cc1nc(-c2ccc(Br)c(C)c2)n[nH]1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
MAPK14 Q16539 6/20 0.44
S1PR1 P21453 1/20 0.41
GSK3B P49841 1/20 0.40
RAF1 P04049 1/20 0.39
NTRK1 P04629 1/20 0.39
HTR1B P28222 1/20 0.39
AOC3 Q16853 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
TYMP P19971 1/20 0.37
PLCG1 P19174 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15117072 0.80 NPC1 (0.64) CYP1A2CYP2C9MEN1NPC1ALDH1A1
SCHEMBL15026739 0.79 HDAC3 (0.46) HDAC3HDAC6NCOR2MAPK14GSK3B
SCHEMBL10067982 0.79 S1PR1 (0.48) S1PR1CYP1A2TYMPNPC1ALDH1A1
SCHEMBL26107873 0.79 HDAC3 (0.65) HDAC3HDAC6NCOR2MAPK14GSK3B
SCHEMBL15299350 0.78 HDAC3 (0.60) HDAC3HDAC6NCOR2MAPK14AOC3
SCHEMBL22052709 0.76 ALDH1A1 (0.64) HDAC3HDAC6NCOR2CYP1A2CYP2C9
SCHEMBL3340613 0.76 MAPK14 (0.47) HDAC3HDAC6NCOR2MAPK14GSK3B
SCHEMBL13545717 0.74 NOTUM (0.52) HDAC3HDAC6NCOR2NPC1RAB9A
SCHEMBL1039187 0.74 NR1H2 (0.59) HDAC3HDAC6NCOR2MAPK14AOC3
SCHEMBL18533192 0.73 MAPT (0.49) S1PR1CYP1A2TYMPMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799226-B1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2001-02-07 EP disclosed
US-5972951-A Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1999-10-26 US disclosed
WO-1996019477-A1 TETRACYCLIC SPIRO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS 5HT1D RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1996-06-27 WO disclosed
US-5510350-A USEFUL IN TREATMENT OR PROPHYLAXIS OF DEPRESSION AND OTHER CENTRAL NERVOUS SYSTEM DISORDERS GLAXO GROUP LIMITED (GB) 1996-04-23 US disclosed
US-5340810-A Useful in the treatment and prophylaxis of depression and other disorders of the central nervous system GLAXO GROUP LIMITED (GB) 1994-08-23 US disclosed
EP-0533268-A1 Benzanilide derivatives as 5-HT1D antagonists GLAXO GROUP LIMITED (GB) 1993-03-24 EP disclosed